PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-18.58%
Revenue decline while VET shows 0.32% growth. Joel Greenblatt would examine competitive position erosion.
137.65%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
-40.04%
Gross profit decline while VET shows 3.63% growth. Joel Greenblatt would examine competitive position.
-26.36%
Margin decline while VET shows 3.30% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.01%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-44.55%
Operating expenses reduction while VET shows 13.46% growth. Joel Greenblatt would examine advantage.
1.85%
Total costs growth 50-75% of VET's 2.92%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
3.17%
D&A growth 1.25-1.5x VET's 2.21%. Martin Whitman would scrutinize asset base.
-27.46%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-19.25%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-37.43%
Both companies show declining income. Martin Whitman would check industry conditions.
-23.15%
Both companies show margin pressure. Martin Whitman would check industry conditions.
196.17%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-28.40%
Both companies show declining income. Martin Whitman would check industry conditions.
-12.05%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-91.87%
Both companies reducing tax expense. Martin Whitman would check patterns.
46.26%
Net income growth while VET declines. John Neff would investigate advantages.
79.65%
Net margin growth while VET declines. John Neff would investigate advantages.
49.37%
EPS growth while VET declines. John Neff would investigate advantages.
49.94%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-16.13%
Share count reduction while VET shows 1.13% change. Joel Greenblatt would examine strategy.
-16.23%
Diluted share reduction while VET shows 1.94% change. Joel Greenblatt would examine strategy.